{
  "id": 15653395,
  "title": "FDA Expands Ryzumvi Approval to Include Presbyopia",
  "url": "https://urgent.news/2026/10/19/fda-expands-ryzumvi-approval-to-include-presbyopia",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T19:48:09.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/ophthalmology/generalophthalmology/123467"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- People with aging-associated farsightedness gained a new topical treatment option as the FDA expanded the approval of phentolamine ophthalmic solution 0.75% (Ryzumvi) to include presbyopia, according to Opus Genetics and Viatris...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}